Lambert-Eaton Myasthenic Syndrome - 22 Studies Found
Available |
: Treatment Use of 3,4 Diaminopyridine in Congenital Myasthenia and Lambert-Eaton Syndrome :
|
Available |
: 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome (LEMS) and Congenital Myasthenia (CM) :
|
Available |
: Expanded Access Study Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS), Congenital Myasthenic Syndrome (CMS), or Downbeat Nystagmus Patients :
|
Recruiting |
: Amifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes : Myasthenic Syndromes, Congenital : 2015-09-24 :
|
Available |
: Treatment Use of 3,4-Diaminopyridine :
|
Completed |
: Pregnancy Outcomes in Congenital Myasthenie Syndrome : Congenital Myasthenic Syndrome : 2011-11-16 |
Completed |
: Ephedrine for the Treatment of Congenital Myasthenia : Myasthenic Syndromes, Congenital : 2007-10-07 : Drug: Ephedrine |
Enrolling by invitation |
: Controlled Trial of 3,4-Diaminopyridine (3-4DAP) in Lambert-Eaton Myasthenic Syndrome (LEMS) : Muscle Weakness : 2014-03-14 : Drug: 3-4 Diaminopyridine Other Name: 3-4 DAP |
Recruiting |
: National Registry for Egyptian Pediatric Neuromuscular Diseases :
|